ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1876

Automated Case Identification of Patients with End-Stage Renal Disease and Systemic Lupus Erythematosus Using Machine Learning

Mario Felix1 and Lais Osmani2, 1Yale, Hamden, CT, 2Yale, New Haven, CT

Meeting: ACR Convergence 2024

Keywords: Lupus nephritis, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease, with 4-28% of patients developing End-Stage Renal Disease (ESRD). Accurate identification of these patients is essential for research and resource allocation. Typically, case identification either involves using administrative claims or diagnostic code data or manual parsing through large datasets, which can be inaccurate and time-consuming. This study aims to develop a machine learning model to efficiently and accurately identify patients with SLE and ESRD from large datasets, and to evaluate the impact of incorporating social determinants of health (SDOH) data on model performance.

Methods: We utilized the NIH “All of Us” dataset, which includes diverse demographic and SDOH data, to create a cohort of patients with SLE. Clinical and SDOH features were used to build and evaluate machine learning models (Random Forest and XGBoost). The dataset was split into training (80%) and test (20%) sets. Model performance was assessed using accuracy, precision, recall, F1-score, and AUC. SHAP values were used to interpret model predictions.

Results: The study cohort included 1101 patients, with 65 having ESRD. XGBoost models outperformed Random Forest models, achieving AUCs of 0.93 (with SDOH) and 0.94 (without SDOH), compared to 0.92 (with SDOH) and 0.89 (without SDOH) for Random Forest. Incorporating SDOH data improved the precision and F1-scores of the XGBoost models. Feature Importance Rankings from XGBoost Model (w/ SDOH) indicated that SDOH variables, particularly those related to healthcare utilization and costs, were among the top 20 features influencing model predictions.

Conclusion: XGBoost models demonstrated superior performance in identifying patients with SLE and ESRD. The inclusion of SDOH data enhanced model precision and real-world interpretability. This study supports the feasibility of using machine learning for automated case identification in large datasets, although addressing class imbalance and model generalizability remains crucial for future work.

Supporting image 1

Classification report demonstrating performance metrics for XgBoost and Random Forest Models with and without incorporation of social determinants of health (SDOH) variables

Supporting image 2

ROC Curves comparing XGBoost and Random Forest models with and without SDOH virables

Supporting image 3

Feature Variable Importance Rankings of the XGBoost Models with and without SDOH variables


Disclosures: M. Felix: None; L. Osmani: None.

To cite this abstract in AMA style:

Felix M, Osmani L. Automated Case Identification of Patients with End-Stage Renal Disease and Systemic Lupus Erythematosus Using Machine Learning [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/automated-case-identification-of-patients-with-end-stage-renal-disease-and-systemic-lupus-erythematosus-using-machine-learning/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automated-case-identification-of-patients-with-end-stage-renal-disease-and-systemic-lupus-erythematosus-using-machine-learning/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology